Breakthrough in Understanding Motor Neuron Disease

Researchers have made a key discovery in understanding motor neuron disease (MND). MND is a devastating condition which causes progressive paralysis, changes in thinking, increasing physical disability.

Trinity College Dublin researchers have made a key discovery in understanding motor neuron disease (MND).

This breakthrough will be extremely valuable in identifying patients for clinical trials and will assist in finding new treatments for this devastating disease.

Blood Test Could Diagnose Motor Neuron Disease
Researchers the University of Sussex identified unique biomarker opening door to future developments allowing quicker diagnosis of motor neurone disease.

‘Motor neuron disease (MND) has 4 distinct patterns of changes in electrical signals that can be identified using EEG (electroencephalography).’

The study has been published online today in the prestigious journal Brain HERE.

MND is a devastating condition which causes progressive paralysis, changes in thinking, increasing physical disability and ultimately death within an average of two to three years. There are over 500 people in Ireland with MND, and one person is diagnosed every 3 days with the condition. There is currently no effective treatment.

While trials of new drugs are being undertaken, MND is known to be very heterogeneous with different patterns of disability and life expectancy. Predicting in advance the pattern of disability and life expectancy is one of the major challenges in designing modern clinical trials.

Statins to Protect Against Motor Neuron Disease
High cholesterol has been found to be a risk factor for the development of motor neuron disease (MND), according to a new study.

The world class electrical signal analysis research developed within Trinity College has discovered different patterns of brain network disruption reflect the underlying disease process. The Trinity researchers have now shown that these patterns of brain network disruptions in MND cluster into 4 distinct subtypes that are predictive of how the disease progresses. The team’s findings move the Trinity researchers one step closer to building better and more effective treatments for different sub-categories of the disease.

The work was performed by Mr Stefan Dukic, a PhD student within the Academic Unit of Neurology at Trinity, under the supervision of Dr Bahman Nasseroleslami, Fr Tony Coote Assistant Professor in Neuroelectric Signal Analysis.

Drug Combination to Relieve Symptoms of Motor Neuron Disease
Nabiximol oral spray containing tetrahydrocannabinol and cannabidiol relieves spasticity more when compared to placebo among patients with motor neuron disease.

Dr Bahman Nasseroleslami said:

Understanding how brain networking is disrupted in MND has been the focus of our research for the past 10 years. This work show that we are on the right track, and that the technologies we have developed to capture electrical activity in the brain can identify important differences between different patient groups.

New Assistive On-screen Keyboard Helps Communicate Patients With Motor Neuron Diseases
OptiKey pairs with third party eye-tracking devices to help those with severe motor or speech limitations to communicate more effectively.

Professor Orla Hardiman, Professor of Neurology and a world leader in MND research said:

This is a very important and exciting body of work. A major barrier to providing the right drug for the right patient in MND is the heterogeneity of the disease. This breakthrough research has shown that it is possible to use patterns of brain network dysfunction to identify subgroups of patients that cannot be distinguished by clinical examination. The implications of this work are enormous, as we will have new and reliable ways segregate patients based on what is really happening within the nervous system in MND.

The paper, ‘Resting-state EEG reveals four subphenotypes of amyotrophic lateral sclerosis’ can be read, in open access, here: https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awab322/6430106

Source-Eurekalert